Logo

Hikal Ltd.

HIKAL Share PricePharmaceuticals & Drugs

342.85

2.4 (0.7%)

As on July 14, 2025

Exchange Scrips: BSE524735NSEHIKALISININE475B01022

Market Cap4,221 Cr

P/E Ratio 60.74

Dividend Yield 0.18 %

Hikal Ltd. Performance

Market performance

Open340
High345.7
Volumes1,92,078
Prev342.85
Low336.4
As on2025-07-14

Historical performance

1 Year High464.75
3 Year High464.75
5 Year High742
1 Year Low309.15
3 Year Low243.1
5 Year Low120.85

Hikal Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
4,221
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
60.74
Dividend Yield
Dividend Yield
0.18 %

Hikal Ltd. Investment Returns

1 Year
-4.9%
3 Years
38.6%
5 Years
183.8%
10 Years
289%

Hikal Ltd. Technicals

IndicatorsValueSignal
5-DMA342.05Bullish
10-DMA343.75Bearish
20-DMA353.23Bearish
50-DMA372.77Bearish
100-DMA380.77Bearish
200-DMA379.12Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters2222222222
Foreign Investors---------------
Domestic Investors2222222222
Public Investors6888571779718907095671818
Government11---------

Hikal Ltd. Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 60.74.
  • 3Y Stock Price CAGR of the stock is 11.5.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹2695 Million.
  • The company generated revenue of ₹17846 Million in the previous financial year.

Hikal Ltd.

342.852.4   (0.7%)

Investment Amount: ₹ 1000000
Current Value: ₹ 954880.9
No. of Shares: 2785 (Approx)
Performance:-4.5%
P/L: ₹-45119.1

Top Gainers

SymbolChange%
SUVIDHAA4.82(20%)
BBTCL194.35(19%)
OLAELEC47.07(18%)
NEULANDLAB14548(18%)
JPPOWER27.23(15%)

Top Losers

SymbolChange%
WEL153.99(-14%)
VERTOZ79.96(-8%)
SALONA260.15(-8%)
GEPIL306.7(-8%)
SIGNPOST246.63(-6%)
GODHA0.62(-6%)
SETUINFRA0.79(-6%)
SPMLINFRA261.32(-6%)

Peer Comparison

Solara Active Pharma Sciences Ltd.

33.3%

673.45

1 Month Performance

Glenmark Pharmaceuticals Ltd.

32.9%

2219.2

1 Month Performance

Zota Health Care Ltd.

26.2%

1216.3

1 Month Performance

Aarey Drugs & Pharmaceuticals Ltd.

25.9%

69.58

1 Month Performance

NGL Fine-Chem Ltd.

24%

1302.5

1 Month Performance

Laurus Labs Ltd.

23.6%

823.85

1 Month Performance

Brooks Laboratories Ltd.

23.1%

154.67

1 Month Performance

Suven Life Sciences Ltd.

22.6%

289.48

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month